Skip to main content
Menu
US

LANCE Ultra Anti-2-methyl K27 Histone H3 Antibody, 10µg

Europium-labeled monoclonal antibody recognizing human Histone H3 mono- and di-methylated at lysine 27 (H3K27me2-1). For use in LANCE® Ultra epigenetic writer and eraser assays.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Click to copy promo code to clipboard.
SAVE 15% NOW on online orders. Use promo code below.
YEAREND15
Offer valid until 12/15. Terms and conditions apply.
Feature Specification
Application Biochemical Enzymatic Assay

Europium-labeled monoclonal antibody recognizing human Histone H3 mono- and di-methylated at lysine 27 (H3K27me2-1). For use in LANCE® Ultra epigenetic writer and eraser assays.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Click to copy promo code to clipboard.
SAVE 15% NOW on online orders. Use promo code below.
YEAREND15
Offer valid until 12/15. Terms and conditions apply.
Product Variants
Unit Size: 10 µg
Part #:
TRF0406-D
List Price
USD 4,966.00
Unit Size: 100 µg
Part #:
TRF0406-M
List Price
USD 12,490.00

Overview

The LANCE® Ultra Europium-anti-di/mono-methyl-Histone H3 Lysine 27 (H3K27me2-1) antibody was used for the development and optimization of a EZH2 methyltransferase assay using a biotinylated Histone H3 (21-44) as substrate. A JMJD3 demethylase assay was also developed, using a biotinylated Histone H3 (21-44) peptide tri-methylated at lysine 27 as substrate. A technical note describing the assay is available in our product literature.

Formats:

  • 10 µg = 1,500 assay points (384-well assay format)
  • 100 µg = 15,000 assay points (384-well format)

Proven, cost-efficient LANCE Ultra reagents can be used to quantitate peptide modifications, detecting specific meythylation and acetylation states. No wash, homogenous LANCE Ultra reagents are HTS friendly - design your own epigenetics screening strategy for greatest efficiency.

Epigenetic enzymatic assays are optimized using a biotinylated histone H3-derived peptide as substrate. The modified peptide is captured by the Eu-labeled antibody (Ab) and ULight-Streptavidin (SA) which bring the Eu donor and ULight acceptor dye molecules into close proximity. Upon irradiation at 320 or 340 nm, the energy from the Eu donor is transferred to the ULight acceptor dye which, in turn, generates light at 665 nm. The intensity of the light emission is proportional to the level of biotinylated substrate modification.

Specifications

Application
Biochemical Enzymatic Assay
Automation Compatible
Yes
Brand
LANCE Ultra
Conjugates
Anti-H3K27me2
Detection Modality
LANCE
Fluorophore
Eu-W1024
Molecular Modification
Methylation
Product Group
Antibody
Shipping Conditions
Shipped in Dry Ice
Target Class
Epigenetics
Technology
TR-FRET
Therapeutic Area
Oncology
Unit Size
10 µg

Resources

Are you looking for resources, click on the resource type to explore further.

1-2 of 2 Resources
Whitepaper Icon
Whitepaper
Epigenetic modifications and how they relate to cancer development and therapy

Epigenetic modifications in cancer

The field of epigenetics has revealed revolutionary methods for understanding heredity...

Product Info Icon
Product Info
LANCE and LANCE Ultra TR-FRET technology product list

LANCE™ Ultra TR-FRET is a no-wash proximity assay technology that combines the benefits of time resolution (TR) with fluorescence...

Scroll Icon